ID   FKS1_YEAST              Reviewed;        1876 AA.
AC   P38631; D6VYY0; Q53YZ4; Q6TKS9; Q6TKT0;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   07-APR-2021, entry version 185.
DE   RecName: Full=1,3-beta-glucan synthase component FKS1;
DE            EC=2.4.1.34;
DE   AltName: Full=1,3-beta-D-glucan-UDP glucosyltransferase;
DE   AltName: Full=Calcineurin dependent protein 1;
DE   AltName: Full=Calcofluor white hypersensitivity protein 53;
DE   AltName: Full=Echinocandin target gene protein 1;
DE   AltName: Full=FK506 sensitivity protein 1;
DE   AltName: Full=Glucan synthase of cerevisiae protein 1;
DE   AltName: Full=Papulacandin B resistance protein 1;
GN   Name=FKS1; Synonyms=CND1, CWH53, ETG1, GLS1, GSC1, PBR1;
GN   OrderedLocusNames=YLR342W; ORFNames=L8300.6;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TOPOLOGY, AND DISRUPTION PHENOTYPE.
RC   STRAIN=RC118D;
RX   PubMed=7530227; DOI=10.1016/0378-1119(94)90633-5;
RA   Eng W.-K., Faucette L., McLaughlin M.M., Cafferkey R., Koltin Y.,
RA   Morris R.A., Young P.R., Johnson R.K., Livi G.P.;
RT   "The yeast FKS1 gene encodes a novel membrane protein, mutations in which
RT   confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent
RT   growth.";
RL   Gene 151:61-71(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], GENE NAME, ENZYME ACTIVITY, TOPOLOGY,
RP   AND DISRUPTION PHENOTYPE.
RC   STRAIN=S288c / GRF88;
RX   PubMed=7528927; DOI=10.1073/pnas.91.26.12907;
RA   Douglas C.M., Foor F., Marrinan J.A., Morin N., Nielsen J.B., Dahl A.M.,
RA   Mazur P., Baginsky W., Li W., El-Sherbeini M., Clemas J.A., Mandala S.M.,
RA   Frommer B.R., Kurtz M.B.;
RT   "The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane
RT   protein which is a subunit of 1,3-beta-D-glucan synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:12907-12911(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND GENE NAME.
RC   STRAIN=ATCC 200589 / A451;
RX   PubMed=7649185; DOI=10.1111/j.1432-1033.1995.0845d.x;
RA   Inoue S.B., Takewaki N., Takasuka T., Mio T., Adachi M., Fujii Y.,
RA   Miyamoto C., Arisawa M., Furuichi Y., Watanabe T.;
RT   "Characterization and gene cloning of 1,3-beta-D-glucan synthase from
RT   Saccharomyces cerevisiae.";
RL   Eur. J. Biochem. 231:845-854(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND GENE NAME.
RC   STRAIN=S288c / GRF88;
RX   PubMed=7828729; DOI=10.1016/0014-5793(94)01418-z;
RA   Ram A.F.J., Brekelmans S.S.C., Oehlen L.J.W.M., Klis F.M.;
RT   "Identification of two cell cycle regulated genes affecting the beta 1,3-
RT   glucan content of cell walls in Saccharomyces cerevisiae.";
RL   FEBS Lett. 358:165-170(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], GENE NAME, ENZYME ACTIVITY, AND
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=S288c / GRF88;
RX   PubMed=7592316; DOI=10.1128/jb.177.20.5732-5739.1995;
RA   Castro C., Ribas J.C., Valdivieso M.H., Varona R., del Rey F., Duran A.;
RT   "Papulacandin B resistance in budding and fission yeasts: isolation and
RT   characterization of a gene involved in (1,3)beta-D-glucan synthesis in
RT   Saccharomyces cerevisiae.";
RL   J. Bacteriol. 177:5732-5739(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], GENE NAME, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7542741; DOI=10.1128/mcb.15.8.4103;
RA   Garrett-Engele P., Moilanen B., Cyert M.S.;
RT   "Calcineurin, the Ca2+/calmodulin-dependent protein phosphatase, is
RT   essential in yeast mutants with cell integrity defects and in mutants that
RT   lack a functional vacuolar H(+)-ATPase.";
RL   Mol. Cell. Biol. 15:4103-4114(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TOPOLOGY, MUTAGENESIS OF ASN-470 AND
RP   LEU-642, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 96519 / YPH250;
RX   PubMed=14693557; DOI=10.1128/aac.48.1.319-322.2004;
RA   Ohyama T., Miyakoshi S., Isono F.;
RT   "FKS1 mutations responsible for selective resistance of Saccharomyces
RT   cerevisiae to the novel 1,3-beta-glucan synthase inhibitor arborcandin C.";
RL   Antimicrob. Agents Chemother. 48:319-322(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169871;
RA   Johnston M., Hillier L.W., Riles L., Albermann K., Andre B., Ansorge W.,
RA   Benes V., Brueckner M., Delius H., Dubois E., Duesterhoeft A.,
RA   Entian K.-D., Floeth M., Goffeau A., Hebling U., Heumann K.,
RA   Heuss-Neitzel D., Hilbert H., Hilger F., Kleine K., Koetter P., Louis E.J.,
RA   Messenguy F., Mewes H.-W., Miosga T., Moestl D., Mueller-Auer S.,
RA   Nentwich U., Obermaier B., Piravandi E., Pohl T.M., Portetelle D.,
RA   Purnelle B., Rechmann S., Rieger M., Rinke M., Rose M., Scharfe M.,
RA   Scherens B., Scholler P., Schwager C., Schwarz S., Underwood A.P.,
RA   Urrestarazu L.A., Vandenbol M., Verhasselt P., Vierendeels F., Voet M.,
RA   Volckaert G., Voss H., Wambutt R., Wedler E., Wedler H., Zimmermann F.K.,
RA   Zollner A., Hani J., Hoheisel J.D.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XII.";
RL   Nature 387:87-90(1997).
RN   [9]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [10]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=7510323; DOI=10.1099/00221287-139-12-2973;
RA   Parent S.A., Nielsen J.B., Morin N., Chrebet G., Ramadan N., Dahl A.M.,
RA   Hsu M.J., Bostian K.A., Foor F.;
RT   "Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of
RT   Saccharomyces cerevisiae.";
RL   J. Gen. Microbiol. 139:2973-2984(1993).
RN   [11]
RP   INDUCTION.
RX   PubMed=7565718; DOI=10.1128/mcb.15.10.5671;
RA   Mazur P., Morin N., Baginsky W., el-Sherbeini M., Clemas J.A.,
RA   Nielsen J.B., Foor F.;
RT   "Differential expression and function of two homologous subunits of yeast
RT   1,3-beta-D-glucan synthase.";
RL   Mol. Cell. Biol. 15:5671-5681(1995).
RN   [12]
RP   ENZYME ACTIVITY, AND INTERACTION WITH RHO1.
RX   PubMed=8662910; DOI=10.1074/jbc.271.24.14604;
RA   Mazur P., Baginsky W.;
RT   "In vitro activity of 1,3-beta-D-glucan synthase requires the GTP-binding
RT   protein Rho1.";
RL   J. Biol. Chem. 271:14604-14609(1996).
RN   [13]
RP   INTERACTION WITH RHO1, AND SUBCELLULAR LOCATION.
RX   PubMed=8602515; DOI=10.1126/science.272.5259.279;
RA   Qadota H., Python C.P., Inoue S.B., Arisawa M., Anraku Y., Zheng Y.,
RA   Watanabe T., Levin D.E., Ohya Y.;
RT   "Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-beta-
RT   glucan synthase.";
RL   Science 272:279-281(1996).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11856368; DOI=10.1046/j.1356-9597.2001.00495.x;
RA   Utsugi T., Minemura M., Hirata A., Abe M., Watanabe D., Ohya Y.;
RT   "Movement of yeast 1,3-beta-glucan synthase is essential for uniform cell
RT   wall synthesis.";
RL   Genes Cells 7:1-9(2002).
RN   [15]
RP   ENZYME ACTIVITY, AND MUTAGENESIS OF LYS-877; ALA-899 AND GLN-977.
RX   PubMed=12399379;
RA   Sekiya-Kawasaki M., Abe M., Saka A., Watanabe D., Kono K.,
RA   Minemura-Asakawa M., Ishihara S., Watanabe T., Ohya Y.;
RT   "Dissection of upstream regulatory components of the Rho1p effector, 1,3-
RT   beta-glucan synthase, in Saccharomyces cerevisiae.";
RL   Genetics 162:663-676(2002).
RN   [16]
RP   ENZYME ACTIVITY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLU-146; VAL-302;
RP   TYR-329; TYR-335; THR-605; ILE-713; ILE-722; MET-761; ALA-823; THR-828;
RP   ILE-853; LEU-855; LEU-872; LYS-877; ALA-899; GLU-907; ASP-920; ALA-932;
RP   GLU-934; GLN-977; ASN-982; PHE-1020; ILE-1047; GLU-1111; PHE-1258 AND
RP   ASN-1520.
RX   PubMed=12185837; DOI=10.1002/yea.866;
RA   Dijkgraaf G.J.P., Abe M., Ohya Y., Bussey H.;
RT   "Mutations in Fks1p affect the cell wall content of beta-1,3- and beta-1,6-
RT   glucan in Saccharomyces cerevisiae.";
RL   Yeast 19:671-690(2002).
RN   [17]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-910, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=14557538; DOI=10.1073/pnas.2135500100;
RA   Hitchcock A.L., Auld K., Gygi S.P., Silver P.A.;
RT   "A subset of membrane-associated proteins is ubiquitinated in response to
RT   mutations in the endoplasmic reticulum degradation machinery.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12735-12740(2003).
RN   [18]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 76625 / YPH499;
RX   PubMed=14576278; DOI=10.1073/pnas.2135385100;
RA   Sickmann A., Reinders J., Wagner Y., Joppich C., Zahedi R.P., Meyer H.E.,
RA   Schoenfisch B., Perschil I., Chacinska A., Guiard B., Rehling P.,
RA   Pfanner N., Meisinger C.;
RT   "The proteome of Saccharomyces cerevisiae mitochondria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13207-13212(2003).
RN   [19]
RP   CASPOFUNGIN HYPERSENSITIVITY.
RX   PubMed=15166135; DOI=10.1534/genetics.167.1.35;
RA   Lesage G., Sdicu A.-M., Menard P., Shapiro J., Hussein S., Bussey H.;
RT   "Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a
RT   synthetic interaction network and altered sensitivity to caspofungin.";
RL   Genetics 167:35-49(2004).
RN   [20]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=17142567; DOI=10.1128/ec.00203-06;
RA   Grabinska K.A., Magnelli P., Robbins P.W.;
RT   "Prenylation of Saccharomyces cerevisiae Chs4p Affects Chitin Synthase III
RT   activity and chitin chain length.";
RL   Eukaryot. Cell 6:328-336(2007).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-269 AND THR-272, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [23]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-259; LYS-275; LYS-386;
RP   LYS-910; LYS-915; LYS-1539 AND LYS-1547, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22106047; DOI=10.1002/pmic.201100166;
RA   Starita L.M., Lo R.S., Eng J.K., von Haller P.D., Fields S.;
RT   "Sites of ubiquitin attachment in Saccharomyces cerevisiae.";
RL   Proteomics 12:236-240(2012).
CC   -!- FUNCTION: Alternate catalytic subunit of the 1,3-beta-glucan synthase
CC       (GS). Synthesizes 1,3-beta-glucan, a major structural component of the
CC       yeast cell wall. Involved in cell wall synthesis, maintenance and cell
CC       wall remodeling. {ECO:0000269|PubMed:11856368}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[(1->3)-beta-D-glucosyl](n) + UDP-alpha-D-glucose = [(1->3)-
CC         beta-D-glucosyl](n+1) + H(+) + UDP; Xref=Rhea:RHEA:21476, Rhea:RHEA-
CC         COMP:11146, Rhea:RHEA-COMP:14303, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:37671, ChEBI:CHEBI:58223, ChEBI:CHEBI:58885; EC=2.4.1.34;
CC         Evidence={ECO:0000269|PubMed:12185837, ECO:0000269|PubMed:12399379,
CC         ECO:0000269|PubMed:7528927, ECO:0000269|PubMed:7592316,
CC         ECO:0000269|PubMed:8662910};
CC   -!- SUBUNIT: Component of the 1,3-beta-glucan synthase (GS), composed of
CC       two alternate catalytic subunits FKS1 or GSC2, and a regulatory subunit
CC       RHO1. Interacts with RHO1, which is a GTP-binding protein.
CC       {ECO:0000269|PubMed:8602515, ECO:0000269|PubMed:8662910}.
CC   -!- INTERACTION:
CC       P38631; P06780: RHO1; NbExp=3; IntAct=EBI-7708, EBI-15121;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11856368,
CC       ECO:0000269|PubMed:12185837, ECO:0000269|PubMed:14576278,
CC       ECO:0000269|PubMed:8602515}. Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}. Note=Localizes to the sites of
CC       polarized growth. Colocalizes with cortical actin patches and moves on
CC       the cell surface at the sites of cell wall remodeling. Actin patch
CC       motility is required for the movement. Early at the cell cycle,
CC       localizes at the presumed bud site of the mother cell and at the tip of
CC       the small bud. As the bud enlarges, appears as discernible spots in the
CC       medium-sized bud and these spots colocalize with actin patches. Late in
CC       the cell cycle, disappears in large budded cells, while the actin
CC       patches disperse over the cell. During cytokinesis, is concentrated in
CC       the neck, overlapping with the location of cortical actin patches.
CC   -!- INDUCTION: During vegetative growth. Expressed periodically during the
CC       cell cycle. {ECO:0000269|PubMed:7565718}.
CC   -!- DISRUPTION PHENOTYPE: Cells are hypersensitive to immunosuppressant
CC       drugs FK506 and cyclosporin A (CsA) due to the inhibition of
CC       calcineurin phosphatase activity by the receptor-drug complexes and is
CC       dependent on calcineurin for vegetative growth. It confers a slow
CC       growth phenotype which is partially suppressed by exogenously added
CC       Ca(2+) and exacerbated by EGTA. Simultaneous disruption of CNA1 and
CC       CNA2 or CNB1 is lethal in FKS1-1. Disruption of FPR1 or CPR1 results in
CC       the loss of hypersensitivity. Overexpression of CNA1 or CNA2, in
CC       conjunction with CNB1, results in a significant decrease in
CC       hypersensitivity to FK506 and CsA. FKS1-8 mutant is sensitive to FK506
CC       and cyclosporin A, has increased tendency to lyse and exhibits slow
CC       growth that is improved by the addition of osmotic stabilizing agents.
CC       It is more sensitive to the drugs when grown on galactose compared to
CC       dextrose. ETG1-1 mutant is resistant to the cell wall active
CC       echinocandins, which are inhibitors of 1,3-beta-D-glucan synthase.
CC       ETG1-4 mutant is hypersensitive to the chitin synthase inhibitor
CC       nikkomycin Z. Deletion of FKS1 leads to hypersensitivity to
CC       echinocandin-like antifungal lipopeptide caspofungin, a 1,3-beta-glucan
CC       synthase inhibitor. Deletion mutant also displays a 30% reduction in
CC       1,3-beta-glucan and 15% reduction in alkali-insoluble 1,6-beta-glucan
CC       compared to wild-type. Increases cellular chitin level
CC       (PubMed:17142567). Increases chitin chain length (PubMed:17142567).
CC       {ECO:0000269|PubMed:14693557, ECO:0000269|PubMed:17142567,
CC       ECO:0000269|PubMed:7510323, ECO:0000269|PubMed:7528927,
CC       ECO:0000269|PubMed:7530227, ECO:0000269|PubMed:7542741,
CC       ECO:0000269|PubMed:7592316}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 48 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U08459; AAC13763.1; -; Genomic_DNA.
DR   EMBL; U12893; AAC48981.1; -; Genomic_DNA.
DR   EMBL; D42126; BAA07706.1; -; Genomic_DNA.
DR   EMBL; X80817; CAA56783.1; -; Genomic_DNA.
DR   EMBL; Z46262; CAA86404.1; -; Genomic_DNA.
DR   EMBL; L35923; AAA79760.1; -; Genomic_DNA.
DR   EMBL; AY395693; AAR86935.1; -; Genomic_DNA.
DR   EMBL; AY395694; AAR86936.1; -; Genomic_DNA.
DR   EMBL; AY395695; AAR86937.1; -; Genomic_DNA.
DR   EMBL; U19028; AAB67256.1; -; Genomic_DNA.
DR   EMBL; BK006945; DAA09646.1; -; Genomic_DNA.
DR   PIR; S50235; S50235.
DR   RefSeq; NP_013446.1; NM_001182231.1.
DR   BioGRID; 31604; 518.
DR   ComplexPortal; CPX-1812; 1,3-beta-D-glucan synthase complex, FKS1-RHO1 variant.
DR   DIP; DIP-5749N; -.
DR   IntAct; P38631; 68.
DR   MINT; P38631; -.
DR   STRING; 4932.YLR342W; -.
DR   CAZy; GT48; Glycosyltransferase Family 48.
DR   TCDB; 9.B.119.1.1; the glycan synthase, fks1 (fks1) family.
DR   iPTMnet; P38631; -.
DR   MaxQB; P38631; -.
DR   PaxDb; P38631; -.
DR   PRIDE; P38631; -.
DR   EnsemblFungi; YLR342W_mRNA; YLR342W; YLR342W.
DR   GeneID; 851055; -.
DR   KEGG; sce:YLR342W; -.
DR   SGD; S000004334; FKS1.
DR   VEuPathDB; FungiDB:YLR342W; -.
DR   eggNOG; KOG0916; Eukaryota.
DR   GeneTree; ENSGT00940000176776; -.
DR   HOGENOM; CLU_000844_0_1_1; -.
DR   InParanoid; P38631; -.
DR   OMA; ASELICY; -.
DR   PRO; PR:P38631; -.
DR   Proteomes; UP000002311; Chromosome XII.
DR   RNAct; P38631; protein.
DR   GO; GO:0000148; C:1,3-beta-D-glucan synthase complex; IDA:SGD.
DR   GO; GO:0030479; C:actin cortical patch; IDA:SGD.
DR   GO; GO:0071944; C:cell periphery; HDA:SGD.
DR   GO; GO:0005933; C:cellular bud; HDA:SGD.
DR   GO; GO:0005935; C:cellular bud neck; IDA:SGD.
DR   GO; GO:0005934; C:cellular bud tip; IDA:SGD.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; HDA:SGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:SGD.
DR   GO; GO:0003843; F:1,3-beta-D-glucan synthase activity; IDA:SGD.
DR   GO; GO:0046527; F:glucosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0006075; P:(1->3)-beta-D-glucan biosynthetic process; IDA:SGD.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0051278; P:fungal-type cell wall polysaccharide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0045807; P:positive regulation of endocytosis; IMP:SGD.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:0008361; P:regulation of cell size; IMP:SGD.
DR   InterPro; IPR026899; FKS1-like_dom1.
DR   InterPro; IPR003440; Glyco_trans_48.
DR   Pfam; PF14288; FKS1_dom1; 1.
DR   Pfam; PF02364; Glucan_synthase; 1.
DR   SMART; SM01205; FKS1_dom1; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell shape; Cell wall biogenesis/degradation;
KW   Glycosyltransferase; Isopeptide bond; Membrane; Mitochondrion;
KW   Phosphoprotein; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..1876
FT                   /note="1,3-beta-glucan synthase component FKS1"
FT                   /id="PRO_0000121725"
FT   TOPO_DOM        1..454
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        455..475
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        476..492
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        493..513
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        514..531
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        532..552
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        553..563
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        564..584
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        585..621
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        622..642
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        643..678
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        679..699
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        700..1358
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1359..1379
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1380..1444
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1445..1465
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1466..1469
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1470..1490
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1491..1560
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1561..1581
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1582..1601
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1602..1622
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1623..1643
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1644..1664
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1665..1672
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1673..1695
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1696..1802
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1803..1823
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1824..1876
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         269
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         272
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   CROSSLNK        259
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        275
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        386
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        910
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        915
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        1539
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        1547
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   MUTAGEN         146
FT                   /note="E->V: In 1132; temperature-sensitive mutant; no
FT                   gross alteration in beta-glucan content of cells; when
FT                   associated with N-329; N-335 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         302
FT                   /note="V->N: In 1082; temperature-sensitive mutant; no
FT                   gross alteration in beta-glucan content of cells; when
FT                   associated with DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         329
FT                   /note="Y->N: In 1132; temperature-sensitive mutant; no
FT                   gross alteration in beta-glucan content of cells; when
FT                   associated with V-146; N-335 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         335
FT                   /note="Y->N: In 1132; temperature-sensitive mutant; no
FT                   gross alteration in beta-glucan content of cells; when
FT                   associated with V-146; N-329 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         470
FT                   /note="N->K: In ACR79-5; selectively resistant to
FT                   antibiotic arborcandin C."
FT                   /evidence="ECO:0000269|PubMed:14693557"
FT   MUTAGEN         605
FT                   /note="T->I: In 1093; temperature-sensitive mutant; higher
FT                   beta-glucan content of cells; when associated with T-761
FT                   and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         642
FT                   /note="L->S: In ACR1A3; selectively resistant to antibiotic
FT                   arborcandin C."
FT                   /evidence="ECO:0000269|PubMed:14693557"
FT   MUTAGEN         713
FT                   /note="I->L: In 1163; temperature-sensitive mutant; no
FT                   gross alteration in beta-glucan content of cells; when
FT                   associated with V-722 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         722
FT                   /note="I->V: In 1163; temperature-sensitive mutant; no
FT                   gross alteration in beta-glucan content of cells; when
FT                   associated with L-713 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         761
FT                   /note="M->T: In 1093; temperature-sensitive mutant; higher
FT                   beta-glucan content of cells; when associated with I-605
FT                   and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         823
FT                   /note="A->V: In 1104; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with E-920
FT                   and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         828
FT                   /note="T->A: In 1014; temperature-sensitive mutant; no
FT                   gross alteration in beta-glucan content of cells; partially
FT                   K1 killer toxin-sensitive; when associated with DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         853
FT                   /note="I->T: In 1114; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with G-932;
FT                   D-934; Y-1020; N-1047 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         855
FT                   /note="L->R: In A6; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with DEL-
FT                   GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         872
FT                   /note="L->F: In 1144; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with K-907;
FT                   S-982 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         877
FT                   /note="K->N: In 1154; temperature-sensitive mutant which is
FT                   able to grow at 25 degrees Celsius but fails to grow at
FT                   temperatures above 35 degrees Celsius; defective in 1,3-
FT                   beta-glucan synthesis and thus has lower beta-glucan
FT                   content; hypersensitive to echinocandin B and to a chitin-
FT                   binding reagent, Calcofluor white; fails to grow in a low
FT                   glucose medium; when associated with S-899; P-977 and DEL-
FT                   GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837,
FT                   ECO:0000269|PubMed:12399379"
FT   MUTAGEN         899
FT                   /note="A->S: In 1154; temperature-sensitive mutant which is
FT                   able to grow at 25 degrees Celsius but fails to grow at
FT                   temperatures above 35 degrees Celsius; defective in 1,3-
FT                   beta-glucan synthesis and thus has lower beta-glucan
FT                   content; hypersensitive to echinocandin B and to a chitin-
FT                   binding reagent, Calcofluor white; fails to grow in a low
FT                   glucose medium; when associated with N-877; P-977 and DEL-
FT                   GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837,
FT                   ECO:0000269|PubMed:12399379"
FT   MUTAGEN         907
FT                   /note="E->K: In 1144; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with F-872;
FT                   S-982 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         920
FT                   /note="D->E: In 1104; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with V-823
FT                   and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         932
FT                   /note="A->G: In 1114; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with T-853;
FT                   D-934; Y-1020; N-1047 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         934
FT                   /note="E->D: In 1114; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with T-853;
FT                   G-932; Y-1020; N-1047 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         977
FT                   /note="Q->P: In 1154; temperature-sensitive mutant which is
FT                   able to grow at 25 degrees Celsius but fails to grow at
FT                   temperatures above 35 degrees Celsius; defective in 1,3-
FT                   beta-glucan synthesis and thus has lower beta-glucan
FT                   content; hypersensitive to echinocandin B and to a chitin-
FT                   binding reagent, Calcofluor white; fails to grow in a low
FT                   glucose medium; when associated with N-877; S-899 and DEL-
FT                   GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837,
FT                   ECO:0000269|PubMed:12399379"
FT   MUTAGEN         982
FT                   /note="N->S: In 1144; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with F-872;
FT                   K-907 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         1020
FT                   /note="F->Y: In 1114; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with T-853;
FT                   G-932; D-934; N-1047 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         1047
FT                   /note="I->N: In 1114; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with T-853;
FT                   G-932; D-934; Y-1020 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         1111
FT                   /note="E->G: In F4; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells; when associated with DEL-
FT                   GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         1258
FT                   /note="F->Y: In 1125; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells and partially K1 killer toxin-
FT                   resistant; when associated with D-1520 and DEL-GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   MUTAGEN         1520
FT                   /note="N->D: In 1125; temperature-sensitive mutant; lower
FT                   beta-glucan content of cells and partial K1 killer toxin-
FT                   resistant phenotype; when associated with Y-1258 and DEL-
FT                   GSC2."
FT                   /evidence="ECO:0000269|PubMed:12185837"
FT   CONFLICT        19
FT                   /note="G -> D (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        113
FT                   /note="A -> P (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        236
FT                   /note="I -> V (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        373
FT                   /note="V -> I (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        437
FT                   /note="K -> T (in Ref. 1; AAC13763)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        470
FT                   /note="N -> K (in Ref. 7; AAR86936)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        492
FT                   /note="K -> R (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        642
FT                   /note="L -> S (in Ref. 7; AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1341
FT                   /note="V -> F (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1457
FT                   /note="M -> I (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1790
FT                   /note="T -> S (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1827..1828
FT                   /note="KH -> DQ (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1834
FT                   /note="D -> T (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1844
FT                   /note="I -> V (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1853
FT                   /note="S -> F (in Ref. 1; AAC13763, 6; AAA79760 and 7;
FT                   AAR86935/AAR86936/AAR86937)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1876 AA;  214851 MW;  AD4B4CB8CB28B5D8 CRC64;
     MNTDQQPYQG QTDYTQGPGN GQSQEQDYDQ YGQPLYPSQA DGYYDPNVAA GTEADMYGQQ
     PPNESYDQDY TNGEYYGQPP NMAAQDGENF SDFSSYGPPG TPGYDSYGGQ YTASQMSYGE
     PNSSGTSTPI YGNYDPNAIA MALPNEPYPA WTADSQSPVS IEQIEDIFID LTNRLGFQRD
     SMRNMFDHFM VLLDSRSSRM SPDQALLSLH ADYIGGDTAN YKKWYFAAQL DMDDEIGFRN
     MSLGKLSRKA RKAKKKNKKA MEEANPEDTE ETLNKIEGDN SLEAADFRWK AKMNQLSPLE
     RVRHIALYLL CWGEANQVRF TAECLCFIYK CALDYLDSPL CQQRQEPMPE GDFLNRVITP
     IYHFIRNQVY EIVDGRFVKR ERDHNKIVGY DDLNQLFWYP EGIAKIVLED GTKLIELPLE
     ERYLRLGDVV WDDVFFKTYK ETRTWLHLVT NFNRIWVMHI SIFWMYFAYN SPTFYTHNYQ
     QLVDNQPLAA YKWASCALGG TVASLIQIVA TLCEWSFVPR KWAGAQHLSR RFWFLCIIFG
     INLGPIIFVF AYDKDTVYST AAHVVAAVMF FVAVATIIFF SIMPLGGLFT SYMKKSTRRY
     VASQTFTAAF APLHGLDRWM SYLVWVTVFA AKYSESYYFL VLSLRDPIRI LSTTAMRCTG
     EYWWGAVLCK VQPKIVLGLV IATDFILFFL DTYLWYIIVN TIFSVGKSFY LGISILTPWR
     NIFTRLPKRI YSKILATTDM EIKYKPKVLI SQVWNAIIIS MYREHLLAID HVQKLLYHQV
     PSEIEGKRTL RAPTFFVSQD DNNFETEFFP RDSEAERRIS FFAQSLSTPI PEPLPVDNMP
     TFTVLTPHYA ERILLSLREI IREDDQFSRV TLLEYLKQLH PVEWECFVKD TKILAEETAA
     YEGNENEAEK EDALKSQIDD LPFYCIGFKS AAPEYTLRTR IWASLRSQTL YRTISGFMNY
     SRAIKLLYRV ENPEIVQMFG GNAEGLEREL EKMARRKFKF LVSMQRLAKF KPHELENAEF
     LLRAYPDLQI AYLDEEPPLT EGEEPRIYSA LIDGHCEILD NGRRRPKFRV QLSGNPILGD
     GKSDNQNHAL IFYRGEYIQL IDANQDNYLE ECLKIRSVLA EFEELNVEQV NPYAPGLRYE
     EQTTNHPVAI VGAREYIFSE NSGVLGDVAA GKEQTFGTLF ARTLSQIGGK LHYGHPDFIN
     ATFMTTRGGV SKAQKGLHLN EDIYAGMNAM LRGGRIKHCE YYQCGKGRDL GFGTILNFTT
     KIGAGMGEQM LSREYYYLGT QLPVDRFLTF YYAHPGFHLN NLFIQLSLQM FMLTLVNLSS
     LAHESIMCIY DRNKPKTDVL VPIGCYNFQP AVDWVRRYTL SIFIVFWIAF VPIVVQELIE
     RGLWKATQRF FCHLLSLSPM FEVFAGQIYS SALLSDLAIG GARYISTGRG FATSRIPFSI
     LYSRFAGSAI YMGARSMLML LFGTVAHWQA PLLWFWASLS SLIFAPFVFN PHQFAWEDFF
     LDYRDYIRWL SRGNNQYHRN SWIGYVRMSR ARITGFKRKL VGDESEKAAG DASRAHRTNL
     IMAEIIPCAI YAAGCFIAFT FINAQTGVKT TDDDRVNSVL RIIICTLAPI AVNLGVLFFC
     MGMSCCSGPL FGMCCKKTGS VMAGIAHGVA VIVHIAFFIV MWVLESFNFV RMLIGVVTCI
     QCQRLIFHCM TALMLTREFK NDHANTAFWT GKWYGKGMGY MAWTQPSREL TAKVIELSEF
     AADFVLGHVI LICQLPLIII PKIDKFHSIM LFWLKPSRQI RPPIYSLKQT RLRKRMVKKY
     CSLYFLVLAI FAGCIIGPAV ASAKIHKHIG DSLDGVVHNL FQPINTTNND TGSQMSTYQS
     HYYTHTPSLK TWSTIK
//
